Natural history of nemaline myopathy in Spain
Official title: Natural History Study for Patients With Nemaline Myopathy in Spain
Run by Hospital Universitari Vall d'Hebron Research Institute · NCT07488806 · Data updated 2026-11-12
This program will follow people in Spain who have nemaline myopathy to chart how the condition changes over time and collect clinical, genetic, and functional data for future trials.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | June 2026 |
| Main results expected | June 2031 |
| Study ends | June 2032 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT07488806 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people in Spain with a confirmed clinical and genetic diagnosis of nemaline myopathy (or a compatible muscle biopsy) who can give informed consent and attend visits at the study center.
✕Probably not a fit
Patients seeking immediate access to disease-modifying therapies, those without a confirmed diagnosis, or those unable to travel to Barcelona are unlikely to receive direct therapeutic benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational natural history program enrolls patients with genetically or clinically confirmed nemaline myopathy in Spain to collect retrospective and prospective clinical data. Participants undergo detailed phenotyping including genetic testing, muscle ultrasound, motor function scales, respiratory and cardiac assessments, quality-of-life and neuropsychological measures. The project will track disease progression, define genotype–phenotype relationships, and seek reliable biomarkers and outcome measures for future therapeutic trials. Data collection is standardized to align with international efforts and to facilitate long-term follow-up and recruitment for interventional studies.
Why it matters
Potential benefit: If successful, the program could speed development of treatments by defining outcome measures, identifying biomarkers, and improving patient selection for future clinical trials.
How similar studies have gone: Natural history efforts in other countries for nemaline myopathy and related congenital myopathies have produced useful genotype–phenotype data and trial-ready outcome measures, but NM-specific datasets remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a confirmed clinical and genetic diagnosis of MN (mutations in ACTA1, NEB, TPM2, TPM3, KBTBD13, CFL2, KLHL40, KLHL41, LMOD3, MYPN, TNNT1, TNNT3), or under discussion if they only have a compatible biopsy. * Signed informed consent by the patient or Legal Authority Responsible, and/or assent by the subject (in pediatric population).
Where it's running
-
University Hospital Vall d'Hebron
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Laura Costa-Comellas, M.D.
- Email: laura.costacomellas@vallhebron.cat
- Phone: +34677255332
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how war affects pregnancy decisions and perinatal mental health in Ukrainian women
This observational study tests how wartime stress influences pregnancy choices and perinatal mental health in Ukrainian women who are 18 or older.
-
Measuring muscle health with a handheld electrical impedance device (mScan)
This project will test whether a handheld mScan device can quickly measure muscle health in adults with myopathies and in people without muscle disease by comparing its readings to MRI.
-
Natural history study of LAMA2 muscular dystrophy in children
This study is trying to understand how LAMA2 muscular dystrophy affects children over time to help improve future treatments.
-
Observing walking patterns in patients with neuromuscular diseases
This study is testing how walking patterns change in people with neuromuscular diseases and whether wearable sensors can help track their daily activity and fatigue levels.
-
Understanding muscle fatigability in congenital myopathies
This study is trying to understand how muscle fatigue affects people with congenital myopathies like Central Core Disease and Nemaline Myopathy over two years.
-
Investigating genetic and environmental factors in cardiovascular and renal diseases
This study looks at how genes and the environment affect heart and kidney health over time in families to help us understand what can lead to diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.